368 related articles for article (PubMed ID: 38629716)
1. Deconstructing cancer with precision genome editing.
Johnson GA; Gould SI; Sánchez-Rivera FJ
Biochem Soc Trans; 2024 Apr; 52(2):803-819. PubMed ID: 38629716
[TBL] [Abstract][Full Text] [Related]
2. Translating genomic insights into cardiovascular medicine: Opportunities and challenges of CRISPR-Cas9.
Zhang Y; Karakikes I
Trends Cardiovasc Med; 2021 Aug; 31(6):341-348. PubMed ID: 32603681
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in CRISPR technologies for genome editing.
Song M; Koo T
Arch Pharm Res; 2021 Jun; 44(6):537-552. PubMed ID: 34164771
[TBL] [Abstract][Full Text] [Related]
4. Precision genome editing in the CRISPR era.
Salsman J; Dellaire G
Biochem Cell Biol; 2017 Apr; 95(2):187-201. PubMed ID: 28177771
[TBL] [Abstract][Full Text] [Related]
5. Applications of genome editing tools in precision medicine research.
Li S; Yang YY; Qiu Y; Chen Y; Xu LW; Ding QR
Yi Chuan; 2017 Mar; 39(3):177-188. PubMed ID: 28420614
[TBL] [Abstract][Full Text] [Related]
6. Modern Approaches to Mouse Genome Editing Using the CRISPR-Cas Toolbox and Their Applications in Functional Genomics and Translational Research.
Monteiro CJ; Heery DM; Whitchurch JB
Adv Exp Med Biol; 2023; 1429():13-40. PubMed ID: 37486514
[TBL] [Abstract][Full Text] [Related]
7. Application of CRISPR-mediated genome engineering in cancer research.
Sayin VI; Papagiannakopoulos T
Cancer Lett; 2017 Feb; 387():10-17. PubMed ID: 27000990
[TBL] [Abstract][Full Text] [Related]
8. Genome editing in the mammalian brain using the CRISPR-Cas system.
Nishiyama J
Neurosci Res; 2019 Apr; 141():4-12. PubMed ID: 30076877
[TBL] [Abstract][Full Text] [Related]
9. Prime Editing Promises Greater Precision, Safety.
Cancer Discov; 2020 Jan; 10(1):OF1. PubMed ID: 31740585
[TBL] [Abstract][Full Text] [Related]
10. Prime Editing in Mammals: The Next Generation of Precision Genome Editing.
Wang D; Fan X; Li M; Liu T; Lu P; Wang G; Li Y; Han J; Zhao J
CRISPR J; 2022 Dec; 5(6):746-768. PubMed ID: 36512351
[TBL] [Abstract][Full Text] [Related]
11. New Developments in CRISPR/Cas-based Functional Genomics and their Implications for Research Using Zebrafish.
Prykhozhij SV; Caceres L; Berman JN
Curr Gene Ther; 2017; 17(4):286-300. PubMed ID: 29173171
[TBL] [Abstract][Full Text] [Related]
12. CRISPR: a journey of gene-editing based medicine.
Golkar Z
Genes Genomics; 2020 Dec; 42(12):1369-1380. PubMed ID: 33094378
[TBL] [Abstract][Full Text] [Related]
13. Current applications and future perspective of CRISPR/Cas9 gene editing in cancer.
Wang SW; Gao C; Zheng YM; Yi L; Lu JC; Huang XY; Cai JB; Zhang PF; Cui YH; Ke AW
Mol Cancer; 2022 Feb; 21(1):57. PubMed ID: 35189910
[TBL] [Abstract][Full Text] [Related]
14. Allele-specific genome targeting in the development of precision medicine.
Wu J; Tang B; Tang Y
Theranostics; 2020; 10(7):3118-3137. PubMed ID: 32194858
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in CRISPR-based functional genomics for the study of disease-associated genetic variants.
Kim HS; Kweon J; Kim Y
Exp Mol Med; 2024 Apr; 56(4):861-869. PubMed ID: 38556550
[TBL] [Abstract][Full Text] [Related]
16. [Precision gene editing technologies based on CRISPR/Cas9: a review].
Xue S; Wang S; Liu L; Zhong Q; Cheng Z; Xiao S
Sheng Wu Gong Cheng Xue Bao; 2023 Jul; 39(7):2566-2578. PubMed ID: 37584115
[TBL] [Abstract][Full Text] [Related]
17. Base editing: advances and therapeutic opportunities.
Porto EM; Komor AC; Slaymaker IM; Yeo GW
Nat Rev Drug Discov; 2020 Dec; 19(12):839-859. PubMed ID: 33077937
[TBL] [Abstract][Full Text] [Related]
18. A Review on Advanced CRISPR-Based Genome-Editing Tools: Base Editing and Prime Editing.
Saber Sichani A; Ranjbar M; Baneshi M; Torabi Zadeh F; Fallahi J
Mol Biotechnol; 2023 Jun; 65(6):849-860. PubMed ID: 36547823
[TBL] [Abstract][Full Text] [Related]
19. A CRISPR/CAS9-based strategy targets the personalized chimeric neosequence in fusion-driven cancer genome for precision medicine.
Huang W; Zeng ZC; Wang WT; Sun YM; Chen YQ; Luo XQ; Fang K
Clin Transl Med; 2021 Mar; 11(3):e355. PubMed ID: 33783997
[No Abstract] [Full Text] [Related]
20. CRISPR cancer trial success paves the way for personalized treatments.
Ledford H
Nature; 2022 Nov; 611(7936):433-434. PubMed ID: 36357583
[No Abstract] [Full Text] [Related]
[Next] [New Search]
